President Joe Biden and Sen. Bernie Sanders have formed a strong partnership to showcase the administration’s efforts in reducing the cost of inhalers and other health care needs. This collaboration took place at the Indian Treaty Room at the White House, where Biden expressed gratitude towards Sanders for their long-standing fight against Big Pharma.
Biden and Sanders highlighted the provisions within the Democrats’ comprehensive climate, health care, and tax package to lower health care costs for individuals on Medicare. The package includes a cap of $35 a month for insulin and $2,000 a year for prescription drugs. Notably, this legislation was passed in 2022 without any Republican support.
Despite significant achievements in areas like health care cost reduction, Biden has not received full recognition from the public. Both Biden and Sanders reiterated their commitment to working together to ensure that the cost of inhalers remains affordable, with a cap of $35 per month, compared to the current cost of $200 to $600 without insurance.
Sanders, a Vermont independent, and Biden, who were once rivals for the Democratic nomination in 2020, have come together to collaborate on important policy issues. Their joint efforts to address health care affordability and pressure major inhaler manufacturers mark a continuation of their partnership in advocating for policies that benefit Americans.
